DOE OSTI · 1890222
PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing
Abstract
Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Consequently, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Grimes, Howard, Ciocarlie, Gabriela Felicia, Yu, Bo, Wijesekera, Duminda, Shannon, Greg, Austad, Wayne, Fracchia, Charles, Xu, Donyan, Kurfess, Thomas, Strama, Lisa, Mylrea, Michael, Reid, Bill. 2022-06-02. PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing. https://doi.org/10.1109/msec.2022.3160465
Cite the original work for its findings. Save a collection to share your selection of sources.